The acquisition strengthens UPS’s position in the fast‑growing healthcare logistics market, giving it a dedicated cold‑chain infrastructure that can capture higher‑margin, time‑critical shipments. It also signals intensified competition among global logistics providers to secure end‑to‑end solutions for pharma and biotech clients.
UPS announced the acquisition of Canadian logistics specialist Andlauer Healthcare Group, paying CAD $55 per share for a total of approximately CAD $2.2 billion (about USD $1.6 billion). The deal expands UPS's cold‑chain capabilities for healthcare customers worldwide.
Comments
Want to join the conversation?
Loading comments...